GlyCOVID

GlyCOVID is a dataset of RDFized COVID-19 data related to glycans. Resources will be added incrementally as publications are curated.

Longitudinal Development of Antibody Responses in COVID-19 Patients of Different Severity with ELISA, Peptide, and Glycan Arrays: An Immunological Case Series.
Heidepriem J, et al.
Pathogens. 2021; 10(4):438. https://doi.org/10.3390/pathogens10040438

A longitudinal analysis of three COVID-19 patients with moderate (#1) and mild disease (#2 and #3) was published. Antibody serum responses were analyzed using spike glycoprotein enzyme linked immunosorbent assay (ELISA), full-proteome peptide, and glycan microarrays. In this Glycovid dataset, the data from these glycan microarray experiments have been RDFized. Fluorescence intensity is given in arbitrary fluorescence units (AFU) as reported in this publication.

Source Last Updated
PSICQUIC March 30, 2022
Displaying entries 2976 - 3000 of 4050 in total
Antibody Patient Onset (days) Symptom GlyTouCan ID Arbitrary Fluorescence Units (AFU) ▲
IgA Patient 3 11 mild
G00066MO
426
IgA Patient 3 11 mild
G53168IY
426
IgA Patient 3 11 mild
G61751GZ
426
IgA Patient 3 11 mild
G66937TJ
426
IgA Patient 3 4 mild
G10133VD
426
IgA Patient 1 10 moderate
G07483YN
427
IgA Patient 1 22 moderate
G53168IY
427
IgA Patient 3 4 mild
G41200QS
427
IgA Patient 4 12 mild
G00054MO
427
IgA Patient 4 12 mild
G73271MD
427
IgM Patient 4 12 mild
G82348BZ
427
IgA Patient 1 6 moderate
G94576MN
428
IgM Patient 2 15 mild
G47548GA
428
IgA Patient 3 11 mild
G00051MO
428
IgA Patient 3 11 mild
G72739GY
428
IgA Patient 4 12 mild
G24432YB
428
IgA Patient 1 22 moderate
G07483YN
429
IgA Patient 1 22 moderate
G54064FW
429
IgA Patient 3 11 mild
G17390SF
429
IgA Patient 1 10 moderate
G08520NM
430
IgA Patient 1 10 moderate
G36544AC
430
IgA Patient 2 15 mild
G15209MJ
430
IgA Patient 2 15 mild
G89993FE
430
IgG Patient 2 3 mild
G98240FC
430
IgA Patient 3 4 mild
G96881BQ
430

About Release Notes Help Feedback

International Collaboration

GlyCosmos is a member of the GlySpace Alliance together with GlyGen and Glycomics@ExPASy.

Acknowledgements

Supported by JST NBDC Grant Number JPMJND2204

Partly supported by NIH Common Fund Grant #1U01GM125267-01


Logo License Policies Site Map

Contact: support@glycosmos.org

This work is licensed under Creative Commons Attribution 4.0 International


GlyCosmos Portal v4.1.0

Last updated: December 9, 2024